Tweenvest Stocks

T.Man Pharmaceutical Public Company Limited (SET: TMAN)

Health Care · Pharmaceuticals · TH

฿10.50

-1.87% today · -10.3% 1Y

T.Man Pharmaceutical Public Company Limited (SET: TMAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $125.10M.

Over the last twelve months the share price has lost 10.3%, trading between 9.95 and 13.60.

Tweenvest scores T.Man Pharmaceutical Public Company Limited across four factors: quality 76/100, value 79/100, growth 64/100, dividend 68/100. Its strongest factor is value.

TMAN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$125.10M
Revenue (TTM)
$78.76M
P/E
8.28
EPS
1.27
Dividend yield
6.10%
Beta (5Y)
0.08
52-week high
฿13.60
52-week low
฿9.95
Avg volume (3M)
—
Shares outstanding
400.00M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
BIOBIJOU Co.,Ltd.KOSDAQ: A489460$126.31M₩11,530.00-3.60%
NRx Pharmaceuticals, Inc.NasdaqCM: NRXP$125.68M$2.89-0.52%
Daewon Pharmaceutical Co., Ltd.KOSE: A003220$125.57M₩7,890.00+0.51%
Orient EuroPharma Co., Ltd.TPEX: 4120$125.54MNT$46.10+0.22%
BGM Group Ltd.NasdaqCM: BGM$124.73M$9.96+6.64%
PT Pyridam Farma TbkIDX: PYFA$124.31MRp198.00-5.71%
JW Shinyak CorporationKOSDAQ: A067290$123.01M₩2,965.00-5.57%
Bharat Parenterals LimitedBSE: 541096$122.94MRs1,717.40-9.38%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 4, 2026.